| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Chief Financial Officer | Performance Restricted Stock Unit (PRSU) | 168K | $617K | $3.67 | Dec 6, 2024 | Direct |
| ACHIEVE LIFE SCIENCES, INC. | Chief Financial Officer | Common Stock Options (right to buy) | 72K | Dec 6, 2024 | Direct | ||
| AYTU BIOPHARMA, INC | Chief Financial Officer | Employee Stock Option (Right to Buy) | 13K | Aug 11, 2023 | Direct | ||
| ACHIEVE LIFE SCIENCES, INC. | Chief Financial Officer | No securities are beneficially owned | 0 | Dec 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Dec 6, 2024 | 2 | $0 | 4 | Dec 9, 2024 | Chief Financial Officer |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Dec 5, 2024 | 0 | $0 | 3 | Dec 9, 2024 | Chief Financial Officer |
| AYTU | AYTU BIOPHARMA, INC | Aug 11, 2023 | 1 | $0 | 4 | Aug 15, 2023 | Chief Financial Officer |
| AYTU | AYTU BIOPHARMA, INC | Nov 18, 2022 | 1 | $20.7K | 4/A | Nov 28, 2022 | Chief Financial Officer |
| AYTU | AYTU BIOPHARMA, INC | Jan 17, 2022 | 1 | $0 | 4 | Jan 19, 2022 | Chief Financial Officer |
| AYTU | AYTU BIOPHARMA, INC | Jan 17, 2022 | 0 | $0 | 3 | Jan 19, 2022 | Chief Financial Officer |